Open AccessAssessing methodological quality of Russian clinical practice guidelines and introducing AGREE II instrument in Russia
Author(s) -
Dina Ayratova Lienhard,
Lidiya Vacheslavovna Kisser,
Л. Е. Зиганшина
Publication year - 2018
Publication title -
plos one
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.99
H-Index - 332
ISSN - 1932-6203
DOI - 10.1371/journal.pone.0203328
Subject(s) - guideline , clarity , medicine , quality (philosophy) , domain (mathematical analysis) , family medicine , pathology , mathematics , physics , mathematical analysis , biochemistry , chemistry , quantum mechanics
Background There are multiple organisations in Russia that publish clinical practice guidelines (CPGs). The demand for CPGs and appreciation of their role in healthcare provision has been steadily growing. However, quality and methodology of development of CPGs have not been systematically addressed. Aim To analyse the quality of Russian-produced CPGs for surgical treatment of hepatic-pancreatic-biliary diseases. Methods We searched Russian databases for CPGs, published between 2013 and 2017. We identified 6 relevant documents that met our inclusion criteria. We approached four experts in the field with written and verbal instructions on the use of the AGREE II questionnaire. Results All six CPGs received the highest domain scores for the domain Clarity of Presentation (46%–80%). The lowest domain scores were for the domain Editorial Independence (6%-25%). Overall, the experts put the highest total sum scores to the CPG for treating chronic pancreatitis (70%), while the lowest total sum score was attributed to the CPG for treating acute cholangitis (22%). Conclusions The overall quality of CPGs, as assessed by the four experts with the AGREE II instrument, was low. The highest scoring, best organized and most comprehensive and straightforward CPG was the one for chronic pancreatitis. The AGREE II instrument should be considered for use in Russia by guideline developers to assess existing CPGs and inform the creation of new guidelines.